Navigation Links
New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF
Date:6/30/2009

AMSTERDAM, The Netherlands, June 30 /PRNewswire/ --

- "Study Could Have Major Impact on the Decision-Making Process With Respect to Infertility Treatment"

New data from an economic analysis presented today at this year's European Society of Human Reproduction and Embryology (ESHRE) congress showed that, within the parameters of the simulation model used, the in vitro fertilisation (IVF) treatment MENOPUR (highly-purified human menopausal gonatropin or HP-hMG) offered considerable cost-savings over recombinant follicle stimulating hormone (rFSH).[1] The cost-effectiveness of HP-hMG compared with rFSH suggested by this data could make it a more attractive choice for use in infertility treatment within a fixed healthcare budget.

In today's difficult global financial situation, the cost-effectiveness of infertility treatments, such as IVF, is more important than ever. Experiencing fertility problems is deeply distressing and isolating for couples and the cost of treatment is one of many considerations for people seeking treatment. A recent audit of European infertility patient groups showed that infertile couples are calling for clear information on the cost-effectiveness, as well as the efficacy of individual treatments.[2]

HP-hMG and rFSH are two commonly used hormonal therapies belonging to the class of drugs known as gonadotropins that enhance egg production in IVF treatment. HP-hMG, contains both FSH and hCG-driven (human chorionic gonadotropin) LH-activity (luteinizing hormone). In contrast, rFSH is a recombinant product and contains only rFSH.

"Until recently, discussions regarding funding for infertility treatment services have been hindered by a relative paucity of economic studies of the specific treatments," points out study investigator Dr Jaro Wex from PharmArchitecture, UK.

"Our new study compared success rates and value for money of gonadot
'/>"/>

SOURCE Ferring Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Study Supports Efficacy of Vagus Nerve Stimulation for Treatment-Resistant Depression
2. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
3. Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer
4. Cost-Effectiveness Study Supports Use of EUFLEXXA(TM) by Rheumatologists for Pain Relief in Patients with Knee Osteoarthritis
5. New Data from the Framingham Heart Study Supports PAT Technology to Diagnose Early Cardiovascular Disease
6. Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood
7. Interim Safety Analysis Supports Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma
8. Interim Analysis Supports Continuation of Cell Genesys VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
9. FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
10. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
11. New Clinical Data Further Supports Chromium Picolinates Role in Enhancing Brain Activity in Older Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... , Sept. 16, 2014 CorMedix ... focused on developing and commercializing therapeutic products for ... infectious diseases, announces the amendment and restatement of ... preferred stock and related warrants, as well as ... stock and warrant financing, to remove anti-dilution, price ...
(Date:9/16/2014)... CALGARY, Alberta , Sept. 16, 2014 /PRNewswire/ ... $1.4 billion industry in less than two years, ... along the way. A huge opportunity exists for ... Today, Vivametrica ( http://vivametrica.com/our-video/ ) introduced a first-of-its-kind ... providers based on years of clinical research linking ...
(Date:9/16/2014)... , N.J. and NEW PROVIDENCE, N.J. ... experts will present a paper on the critical ... medical oxygen storage and deliver systems at the American ... will be held at the Chicago Sheraton Hotel and ... Derrick West , program manager of ...
Breaking Medicine Technology:CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 2CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 3Doctors Launch Initiative to Bridge Gap Between Wearables and Meaningful Health Data 2Doctors Launch Initiative to Bridge Gap Between Wearables and Meaningful Health Data 3Linde Healthcare experts to present details on installation of medical oxygen storage and distribution systems at ASPE convention 2Linde Healthcare experts to present details on installation of medical oxygen storage and distribution systems at ASPE convention 3
... 2012 Reportlinker.com announces that a ... in its catalogue: , ... Report & Forecast: 2011-2016 ... in antibody technology has revolutionized both ...
... Texas, Feb. 6, 2012 Luminex Corporation (NASDAQ: ... fourth quarter and year ended December 31, 2011.  Financial ... (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) Consolidated fourth quarter ... over the fourth quarter of 2010; full-year 2011 revenue ...
Cached Medicine Technology:Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2011-2016 2Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2011-2016 3Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2011-2016 4Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2011-2016 5Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2011-2016 6Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2011-2016 7Luminex Corporation Reports Fourth Quarter and Full Year 2011 Results 2Luminex Corporation Reports Fourth Quarter and Full Year 2011 Results 3Luminex Corporation Reports Fourth Quarter and Full Year 2011 Results 4Luminex Corporation Reports Fourth Quarter and Full Year 2011 Results 5Luminex Corporation Reports Fourth Quarter and Full Year 2011 Results 6Luminex Corporation Reports Fourth Quarter and Full Year 2011 Results 7Luminex Corporation Reports Fourth Quarter and Full Year 2011 Results 8Luminex Corporation Reports Fourth Quarter and Full Year 2011 Results 9
(Date:9/16/2014)... (PRWEB) September 16, 2014 The ... Management practice by Ranking Arizona magazine, has selected ... across its enterprise. , With TPC seeing hundreds ... vast data repository that was managed through “home grown” ... the management and clinical leadership teams. “Our current ...
(Date:9/16/2014)... September 16, 2014 Synergy Research Group ... report gives the best detail and analysis of the ... from a variety of sources, including Ministry of Health ... Paper will give readers actionable intelligence on clinical trials ... is relied on by the local and international life ...
(Date:9/16/2014)... 2014 Whatisfinalexpenseinsurance.com has released a ... affordable life insurance for seniors. , Finding affordable life ... A big part of the insurance market has moved ... tips that clients can use when shopping for life ... is important for providing financial security for vulnerable family ...
(Date:9/16/2014)... comparison of five-year sexual function outcomes, as ... radiotherapy (EBRT) versus combination EBRT plus brachytherapy, ... therapy makes cure possible without compromising long-term ... at the American Society for Radiation Oncology,s ... study examined the patient-reported outcomes of 91 ...
(Date:9/16/2014)... San Francisco, September 16, 2014A large, international analysis of ... indicates that a patient,s overall survival (OS) rate can ... metastases develop and lymph node involvement, and that aggressive ... rate of 47.8 percent, according to research presented today ... Annual Meeting. , When lung cancer has spread ...
Breaking Medicine News(10 mins):Health News:The Pain Center of Arizona (TPC) Implements Analance™ BI for Actionable Intelligence 2Health News:The Pain Center of Arizona (TPC) Implements Analance™ BI for Actionable Intelligence 3Health News:Synergy Research Group Debuts Ukraine Orange Paper 2Health News:Life Insurance for Seniors - Clients Can Find Fast Life Insurance By Comparing Online Quotes! 2Health News:Prostate cancer patients surveyed 5 years after vessel-sparing RT report preserved sexual function 2Health News:Prostate cancer patients surveyed 5 years after vessel-sparing RT report preserved sexual function 3Health News:Select group of stage IV lung cancer patients achieve long-term survival after aggressive treatments 2Health News:Select group of stage IV lung cancer patients achieve long-term survival after aggressive treatments 3Health News:Select group of stage IV lung cancer patients achieve long-term survival after aggressive treatments 4
... LONDON, NEW YORK, NORWICH, England and ONGAR, Ireland,Sept. 4 ... announced on the 29th August that it has acquired ... and Safety Monitor was launched at the same time ... and has tracked the developing,legislation since then. It has ...
... Off September,s Ovarian Cancer Awareness ... ... Cancer,Coalition (NOCC) launched its newest educational initiative, Eva,s Divas,with a celebrity red-carpet ... the first to pledge to empower and educate,women nationwide about the symptoms ...
... Inc. (Amex:,ULU) today announced that it is scheduled ... at 3:15 p.m. Eastern Time on Thursday,September 4, ... is an emerging specialty pharmaceutical company focused on,the ... surgery and,oral care products to provide patients and ...
... women are always in search,of easy diets that will help ... have become a little too snug for comfort. Celebrity style,expert ... their,jeans and how they can get their hands on actual ... (See video from Kellogg,s at:, http://media.medialink.com/WebNR.aspx?story=35515 ) On ...
... juice is,thought to ward off HIV/AIDS. In others, homosexuality ... misinformation and stigma, how can,developing countries fight a virus ... Part of the answer is to enlist the power ... media development nonprofit that has,provided in-depth training and mentoring ...
... --- There,s no magic bullet for wiping out malaria, ... method that effectively delays the evolution of drug resistance ... , David Smith, associate director of disease ecology at ... scientists and policy makers in extending the longevity of ...
Cached Medicine News:Health News:Schofield Publishing Enters the Newsletter Market 2Health News:National Ovarian Cancer Coalition and CSI: Miami Star Eva La Rue Launch Eva's Divas in Hollywood to Educate Women Nationwide About Ovarian Cancer 2Health News:National Ovarian Cancer Coalition and CSI: Miami Star Eva La Rue Launch Eva's Divas in Hollywood to Educate Women Nationwide About Ovarian Cancer 3Health News:More than 1,000 Journalists Enlisted in Fight Against HIV/AIDS 2Health News:Study: Delaying evolution of drug resistance in malaria parasite possible 2Health News:Study: Delaying evolution of drug resistance in malaria parasite possible 3
Model 8097 is CSA Certified. Thermo Forma Plasma Freezers safely store single donor, fresh frozen plasma, and cryoprecipitate. Recorders are standard....
... complying with Australian Standard AS3864-1997 suitable to ... grey colorbond steel with a powder coated ... 40-litre capacity polished stainless steel compartment. Lid ... a heated top fascia. A removable chrome ...
... 1400 Series Biosafety Cabinets ... revolutionize working in a ... most comfortable, quiet, and ... cabinet on the market, ...
... 12 Holter Analysis Kit incorporates detection of ... other powerful DMS Holter analysis tools. Premier ... possible in less than 10 seconds and ... visual verification and validation. The TWA algorithm ...
Medicine Products: